Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
Source: news.google.com
Published: Jun 29, 2026 15:10
Source: news.google.com
Published: Jun 29, 2026 15:10
Related Stories
NeuroSense’s ALS drug cuts key biomarker in Phase IIb trial Yahoo
#Clinical TrialsCambridge biotech Alopexx files to go public with $30M IPO The Business Journals
#Biotech HeadlinesWhy I’m Eyeing Prices, Biotech and AI in Q3 TheStreet Pro
#Biotech HeadlinesNew ALS treatment enters human testing in global program ALS News Today
#Clinical TrialsClinical trials are reshaping health outcomes for Colorado residents The Business Journals
#Clinical TrialsReal-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors Applied Clinical Trials Online
#Clinical TrialsAdd Shortcut
Open this site faster like an app from your phone home screen.